AI assistant
THERACRYF PLC — Major Shareholding Notification 2023
Dec 29, 2023
7964_mrq_2023-12-29_00bb2ffa-a6cb-43b1-a6e9-40dd277dd2d2.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 2309Y
Evgen Pharma PLC
29 December 2023
TR-1: Standard form for notification of major holdings
| NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i | |||||
| 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: | |||||
| 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) | |||||
| Non-UK issuer | |||||
| 2. Reason for the notification (please mark the appropriate box or boxes with an "X") | |||||
| An acquisition or disposal of voting rights | |||||
| An acquisition or disposal of financial instruments | |||||
| An event changing the breakdown of voting rights | |||||
| Other (please specify) iii: | |||||
| 3. Details of person subject to the notification obligation iv | |||||
| Name | |||||
| City and country of registered office (if applicable) | |||||
| 4. Full name of shareholder(s) (if different from 3.) v | |||||
| Name | |||||
| City and country of registered office (if applicable) | |||||
| 5. Date on which the threshold was crossed or reached vi: | |||||
| 6. Date on which issuer notified (DD/MM/YYYY): | |||||
| 7. Total positions of person(s) subject to the notification obligation | |||||
| % of voting rights attached to shares (total of 8. A) | |||||
| Resulting situation on the date on which threshold was crossed or reached | 4.87% | ||||
| Position of previous notification (if applicable) |
8.90% | ||||
| 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached | |||||
| A: Voting rights attached to shares viii | |||||
| Class/type of shares ISIN code (if possible) |
Number of voting rights ix | ||||
| Direct (DTR5.1) |
Indirect (DTR5.2.1) |
||||
| GB00BSVYN304 | |||||
| SUBTOTAL 8. A | 13,399,724 | ||||
| B 1: Financial Instruments according to DTR5.3.1R (1) (a) | |||||
| Type of financial instrument | Expiration date x |
||||
| B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b) | |||||
| Type of financial instrument | Expiration date x |
||||
| 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X") |
|||||
| Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii | |||||
| Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv |
|||||
| Name xv | % of voting rights if it equals or is higher than the notifiable threshold | ||||
| AXA Investment Managers S.A. | - | ||||
| AXA Investment Managers UK Holdings Ltd. | - | ||||
| AXA Investment Managers UK Ltd. | 4.87% | ||||
| 10. In case of proxy voting, please identify: | |||||
| Name of the proxy holder | |||||
| The number and % of voting rights held | |||||
| The date until which the voting rights will be held | |||||
| 11. Additional information xvi | |||||
| Place of completion | Paris - La Défense, France | ||||
| Date of completion | 29/12/2023 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
HOLZZMZZMLVGFZM